These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31844979)
1. Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells. Mehner M; Kubelt C; Adamski V; Schmitt C; Synowitz M; Held-Feindt J J Cancer Res Clin Oncol; 2020 Jan; 146(1):117-126. PubMed ID: 31844979 [TBL] [Abstract][Full Text] [Related]
2. Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche. Caylioglu D; Meyer RJ; Hellmold D; Kubelt C; Synowitz M; Held-Feindt J Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808494 [TBL] [Abstract][Full Text] [Related]
3. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy. Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479 [TBL] [Abstract][Full Text] [Related]
4. Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model. Adamski V; Schmitt C; Ceynowa F; Adelung R; Lucius R; Synowitz M; Hattermann K; Held-Feindt J J Cancer Res Clin Oncol; 2018 Aug; 144(8):1475-1485. PubMed ID: 29858681 [TBL] [Abstract][Full Text] [Related]
5. Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells. Hellmold D; Kubelt C; Daunke T; Beckinger S; Janssen O; Hauck M; Schütt F; Adelung R; Lucius R; Haag J; Sebens S; Synowitz M; Held-Feindt J Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240419 [TBL] [Abstract][Full Text] [Related]
7. Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas. Shi L; Sun G; Zhang Y Aging (Albany NY); 2020 Nov; 12(23):23795-23807. PubMed ID: 33221748 [TBL] [Abstract][Full Text] [Related]
8. Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice Huang YP; Ma YS; Kuo CL; Liao CL; Chen PY; Peng SF; Hsu FT; Lai KC Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071132 [TBL] [Abstract][Full Text] [Related]
9. Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro. Shi L; Sun G Neuromolecular Med; 2015 Dec; 17(4):431-42. PubMed ID: 26458914 [TBL] [Abstract][Full Text] [Related]
10. Establishment of a glioblastoma in vitro (in)complete resection dual co-culture model suitable for drug testing. Schmitt C; Adamski V; Rasch F; Adelung R; Lucius R; Synowitz M; Hattermann K; Held-Feindt J Ann Anat; 2020 Mar; 228():151440. PubMed ID: 31726206 [TBL] [Abstract][Full Text] [Related]
11. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation. Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813 [TBL] [Abstract][Full Text] [Related]
12. A biopolymeric mesh enriched with PLGA microparticles loaded with AT101 for localized glioblastoma treatment. Hellmold D; Arnaldi P; Synowitz M; Held-Feindt J; Akbari M Biomed Mater; 2023 Apr; 18(3):. PubMed ID: 37054732 [TBL] [Abstract][Full Text] [Related]
13. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway. Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060 [TBL] [Abstract][Full Text] [Related]
14. Novel Targeting of Transcription and Metabolism in Glioblastoma. Su YT; Chen R; Wang H; Song H; Zhang Q; Chen LY; Lappin H; Vasconcelos G; Lita A; Maric D; Li A; Celiku O; Zhang W; Meetze K; Estok T; Larion M; Abu-Asab M; Zhuang Z; Yang C; Gilbert MR; Wu J Clin Cancer Res; 2018 Mar; 24(5):1124-1137. PubMed ID: 29254993 [No Abstract] [Full Text] [Related]
15. In vitro novel combinations of psychotropics and anti-cancer modalities in U87 human glioblastoma cells. Tzadok S; Beery E; Israeli M; Uziel O; Lahav M; Fenig E; Gil-Ad I; Weizman A; Nordenberg J Int J Oncol; 2010 Oct; 37(4):1043-51. PubMed ID: 20811727 [TBL] [Abstract][Full Text] [Related]
16. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells. Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745 [TBL] [Abstract][Full Text] [Related]
17. Metformin treatment reduces temozolomide resistance of glioblastoma cells. Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206 [TBL] [Abstract][Full Text] [Related]
18. Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models. Jarzabek MA; Amberger-Murphy V; Callanan JJ; Gao C; Zagozdzon AM; Shiels L; Wang J; Ligon KL; Rich BE; Dicker P; Gallagher WM; Prehn JH; Byrne AT Br J Cancer; 2014 Dec; 111(12):2275-86. PubMed ID: 25375271 [TBL] [Abstract][Full Text] [Related]
19. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking. Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066 [TBL] [Abstract][Full Text] [Related]
20. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo. Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]